Global Poultry Vaccines Market by Disease Type (Infectious Bronchitis, Avian Influenza), by Application (Breeder, Broiler), by Product (Attenuated Live, Inactivated) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global poultry vaccines market was valued at USD 2.0 billion in 2018. It is forecast to grow 6.2% over the forecast period. The market is driven by rising demand for poultry-related foods products and vaccinations to reduce avian diseases outbreaks.

The market is also being boosted by a growing awareness among veterinary professionals about animal vaccinations, rising meat consumption, as well as government initiatives to ensure food safety. According to the Middle East Rating Agency (MERA), Qatar established central food labs with various procedures and food safety analyses in April 2019. This was to ensure that consumers receive safe, high-quality, contamination-free meat products.

The market is experiencing a growing poultry population and an increase in avian diseases. This is driving product demand. The National Chicken Council estimates that per capita poultry spending was USD 133.5 in 2016, and USD 135.8 for 2018. Consuming infected meat can pose a risk to human health. It is therefore imperative that birds are vaccinated before they are used. Poultry farms face two main problems: rapid spread of disease and lack of treatment options. Vaccination is mandatory to prevent these situations.

Market growth is being driven by mandatory vaccination of other domesticated and live livestock animals, an increase in poultry inventories, improved livestock productivity, and a greater focus on food safety. MSD & Co. Inc. launched the first live poultry vaccine INNOVAXND-IBD on the U.S. markets in November 2018. Market growth will be accelerated by such innovations from leading players.

Product Insights

In 2018, the largest revenue share was held by attenuated live vaccine. The vaccine is able to stimulate the immune system to produce more antibodies than other types of vaccines. The vaccine provides protection against avian diseases like Newcastle disease, infectious bursal disease and infectious bronchitis. In addition, segment growth is being accelerated by the increase in R&D activities in vaccine research to prevent outbreaks of these diseases.

The protection of specific pathogen-free poultry against disease, death, and virus shedding has been demonstrated by vectored vaccines. These vaccines have also been approved for use in China and Mexico as poultry vaccinations in 2019. This will increase the market share in Asia Pacific and LATAM.

Disease Type Insights

The largest share of revenue in the poultry vaccines market was accounted for by infectious bronchitis as of 2018. This is due to the high risk of the disease from contamination. A 2016 article in Vet Res Journal stated that the disease is highly contagious. It is found in almost all countries where there is high endemicity. According to reports, the disease has a 100% incidence rate among all ages of chickens. It is the natural host of the disease, and can cause severe damage to chickens. This can then lead to human health problems. As preventive measures, companies are actively involved with the production of new vaccines. Cevac, for example, introduced Ceva IBron in February 2017. This vaccine protects against the Georgia (GA-IBV) strains.

Newcastle disease, also called virulent Newcastle virus (VND) and virulent Newcastle diseases virus (NDV), are major diseases that affect domestic poultry and other avian species. The World Organization for Animal Health, (OIE) states that although Newcastle disease has been under control in North America and many western European countries, it is still affecting poultry in South America, Asia, Africa and South America.

Application Insights

In 2018, the largest revenue share was held by the breeder segment. It is expected to grow the fastest over the forecast period due to an increasing number of breeding farms that produce fertile eggs which are then hatched in a hatchery. The market has seen an increase in productivity due to these breeding farms. Pro-active government policies are responsible for the growth of breeder farms. This has led to a growing number of poultry farmers and breeders, as well as integrators and feed mills.

The state's Animal Husbandry Department, Andhra Pradesh, India, increased production in the poultry industry through a comprehensive poultry policy (2016-2020). This policy is intended to increase the production of layers and commercial broilers, and encourage processing eggs and chickens. It also promotes export activities. It also promotes low input, high-tech rearing. These positive initiatives by the government are driving the market.

Regional Insights

North America was the dominant market in the global market. It is expected to maintain its position over the forecast period due to increased consumption of poultry-related products, consumer awareness regarding food safety and high incidences of avian disease. The region's dominance is also due to the high production of poultry meat. The United Nations Food and Agriculture Organization (UNFAO) states that the United States is the world's largest producer of poultry meat, accounting for 18.0% of global production. The adoption of poultry vaccines is also being accelerated by strategic alliances and acquisitions that promote better avian health. Market growth is also being driven by favorable reimbursement policies and increased spending on animal health.

Due to the rapid development in animal husbandry practices and government initiatives to support research and development, the European market will be a strong contender. Due to increased awareness of poultry vaccines, and a surge in vaccination awareness programs, the Asia Pacific market will experience the fastest growth over the forecast period.

Market Share Insights & Key Companies

This market is very competitive and is dominated in part by Merck & Co. Inc., Zoetis; Boehringer Ingelheim International GmbH; Ceva; Hester Biosciences Limited and Anicon GmbH. There are many local and international players looking to expand their market share through strategic moves like new product development, M&As, JVs, partnerships and distribution channel agreements. Ceva Company and IDT Biologika GmbH, for example, announced the successful acquisition of IDT's veterinary pharmaceutical as well as R&D assets by Ceva in July 2019.

Hester Biosciences Limited also had 45 inactivated and live vaccines for the poultry segment. The company has four large-animal vaccines that are live and inactivated, as well as a strong healthcare and diagnostic service. It is expected to increase its presence in large animal healthcare products, poultry health products and large animal vaccines.

Market Report Scope for Poultry Vaccines

The Report Covers Certain Segments

This report predicts revenue growth at the global, regional and country level and offers an analysis of industry trends in each sub-segment from 2014 to 2026. Grand View Research has divided the global poultry vaccines market report by product, disease type and application.

• Product Outlook (Revenue USD Million, 2014-2026)

  • Attenuated Live Vaccines

  • Inactivated Vaccines

  • Subunit Vaccines

  • DNA Vaccines

  • Recombinant Vaccines

• The outlook for disease types (Revenue, USD million, 2014-2026)

  • Infectious Bronchitis

  • Avian Influenza

  • Marek's Disease

  • Newcastle Disease

  • Salmonella

• App Outlook (Revenue USD Million, 2014-2026)

  • Breeder

  • Broiler

  • Layer

• Regional Outlook (Revenue USD Million, 2014-2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

These are the most frequently asked questions about this report

b. Global poultry vaccines market was valued at USD 2.12 Billion in 2019, and is forecast to grow to USD 2.25 Billion by 2020.

b. Global poultry vaccines market will grow at 6.2% compound annual growth rate between 2019 and 2026, to reach USD 3.24 Billion by 2026.

b. With a 35.00% share in 2019, North America was the dominant market for poultry vaccines. This can be attributed to increased poultry-related food product consumption, consumer awareness regarding food safety, and high incidences of avian disease.

b. Merck & Co. Inc., Zoetis; Boehringer Ingelheim International GmbH, Ceva; Hester Biosciences Limited. Anicon GmbH. and Ringpu Biology are some of the key players in the poultry vaccines industry.

b. Market growth is being driven by rising demand for poultry-related products and vaccinations to combat avian diseases outbreaks.

Up Market Research published a new report titled “Poultry Vaccines Market research report which is segmented by Disease Type (Infectious Bronchitis, Avian Influenza), by Application (Breeder, Broiler), by Product (Attenuated Live, Inactivated), By Players/Companies Merck & Co Inc; Zoetis; Boehringer Ingelheim International GmbH; Ceva; Hester Biosciences Limited; Anicon GmbH; and Ringpu Biology”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Poultry Vaccines Market Report Segments:

The market is segmented by Disease Type (Infectious Bronchitis, Avian Influenza), by Application (Breeder, Broiler), by Product (Attenuated Live, Inactivated).

Poultry Vaccines Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Poultry Vaccines Market

Overview of the regional outlook of the Poultry Vaccines Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Poultry Vaccines Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Poultry Vaccines Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Infectious Bronchitis

                2. Avian Influenza

                1. Breeder

                2. Broiler

                1. Attenuated Live

                2. Inactivated

9. Market scenario by region, sub-region, and country.
10. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
11. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
12. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Poultry Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Poultry Vaccines Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.